213 related articles for article (PubMed ID: 37750556)
1. Sustained Increases in Cardiomyocyte Protein
Ha CM; Bakshi S; Brahma MK; Potter LA; Chang SF; Sun Z; Benavides GA; He L; Umbarkar P; Zou L; Curfman S; Sunny S; Paterson AJ; Rajasekaran NS; Barnes JW; Zhang J; Lal H; Xie M; Darley-Usmar VM; Chatham JC; Wende AR
J Am Heart Assoc; 2023 Oct; 12(19):e029898. PubMed ID: 37750556
[TBL] [Abstract][Full Text] [Related]
2. Swim-exercised mice show a decreased level of protein O-GlcNAcylation and expression of O-GlcNAc transferase in heart.
Belke DD
J Appl Physiol (1985); 2011 Jul; 111(1):157-62. PubMed ID: 21493720
[TBL] [Abstract][Full Text] [Related]
3. Fine-tuning the cardiac O-GlcNAcylation regulatory enzymes governs the functional and structural phenotype of the diabetic heart.
Prakoso D; Lim SY; Erickson JR; Wallace RS; Lees JG; Tate M; Kiriazis H; Donner DG; Henstridge DC; Davey JR; Qian H; Deo M; Parry LJ; Davidoff AJ; Gregorevic P; Chatham JC; De Blasio MJ; Ritchie RH
Cardiovasc Res; 2022 Jan; 118(1):212-225. PubMed ID: 33576380
[TBL] [Abstract][Full Text] [Related]
4. Sustained
Tan EP; McGreal SR; Graw S; Tessman R; Koppel SJ; Dhakal P; Zhang Z; Machacek M; Zachara NE; Koestler DC; Peterson KR; Thyfault JP; Swerdlow RH; Krishnamurthy P; DiTacchio L; Apte U; Slawson C
J Biol Chem; 2017 Sep; 292(36):14940-14962. PubMed ID: 28739801
[TBL] [Abstract][Full Text] [Related]
5. High glucose induces mitochondrial dysfunction independently of protein O-GlcNAcylation.
Dassanayaka S; Readnower RD; Salabei JK; Long BW; Aird AL; Zheng YT; Muthusamy S; Facundo HT; Hill BG; Jones SP
Biochem J; 2015 Apr; 467(1):115-26. PubMed ID: 25627821
[TBL] [Abstract][Full Text] [Related]
6. Excessive
Umapathi P; Mesubi OO; Banerjee PS; Abrol N; Wang Q; Luczak ED; Wu Y; Granger JM; Wei AC; Reyes Gaido OE; Florea L; Talbot CC; Hart GW; Zachara NE; Anderson ME
Circulation; 2021 Apr; 143(17):1687-1703. PubMed ID: 33593071
[TBL] [Abstract][Full Text] [Related]
7. O-GlcNAcylation involvement in high glucose-induced cardiac hypertrophy via ERK1/2 and cyclin D2.
Ding F; Yu L; Wang M; Xu S; Xia Q; Fu G
Amino Acids; 2013 Aug; 45(2):339-49. PubMed ID: 23665912
[TBL] [Abstract][Full Text] [Related]
8. Increased O-GlcNAcylation induces myocardial hypertrophy.
Chen X; Zhang L; He H; Sun Y; Shen Q; Shi L
In Vitro Cell Dev Biol Anim; 2020 Oct; 56(9):735-743. PubMed ID: 32996013
[TBL] [Abstract][Full Text] [Related]
9. O-GlcNAc Transferase Promotes Compensated Cardiac Function and Protein Kinase A O-GlcNAcylation During Early and Established Pathological Hypertrophy From Pressure Overload.
Zhu WZ; El-Nachef D; Yang X; Ledee D; Olson AK
J Am Heart Assoc; 2019 Jun; 8(11):e011260. PubMed ID: 31131693
[TBL] [Abstract][Full Text] [Related]
10. Excess protein O-GlcNAcylation and the progression of diabetic cardiomyopathy.
Fricovsky ES; Suarez J; Ihm SH; Scott BT; Suarez-Ramirez JA; Banerjee I; Torres-Gonzalez M; Wang H; Ellrott I; Maya-Ramos L; Villarreal F; Dillmann WH
Am J Physiol Regul Integr Comp Physiol; 2012 Oct; 303(7):R689-99. PubMed ID: 22874425
[TBL] [Abstract][Full Text] [Related]
11. Regulation of cardiac O-GlcNAcylation: More than just nutrient availability.
Collins HE; Chatham JC
Biochim Biophys Acta Mol Basis Dis; 2020 May; 1866(5):165712. PubMed ID: 32014551
[TBL] [Abstract][Full Text] [Related]
12. Increased enzymatic O-GlcNAcylation of mitochondrial proteins impairs mitochondrial function in cardiac myocytes exposed to high glucose.
Hu Y; Suarez J; Fricovsky E; Wang H; Scott BT; Trauger SA; Han W; Hu Y; Oyeleye MO; Dillmann WH
J Biol Chem; 2009 Jan; 284(1):547-555. PubMed ID: 19004814
[TBL] [Abstract][Full Text] [Related]
13. Cardiomyocyte Oga haploinsufficiency increases O-GlcNAcylation but hastens ventricular dysfunction following myocardial infarction.
Dassanayaka S; Brittian KR; Long BW; Higgins LA; Bradley JA; Audam TN; Jurkovic A; Gumpert AM; Harrison LT; Hartyánszky I; Perge P; Merkely B; Radovits T; Hanover JA; Jones SP
PLoS One; 2020; 15(11):e0242250. PubMed ID: 33253217
[TBL] [Abstract][Full Text] [Related]
14. Protein O-GlcNAcylation in cardiovascular diseases.
Wang HF; Wang YX; Zhou YP; Wei YP; Yan Y; Zhang ZJ; Jing ZC
Acta Pharmacol Sin; 2023 Jan; 44(1):8-18. PubMed ID: 35817809
[TBL] [Abstract][Full Text] [Related]
15. Inhibiting O-GlcNAcylation impacts p38 and Erk1/2 signaling and perturbs cardiomyocyte hypertrophy.
Papanicolaou KN; Jung J; Ashok D; Zhang W; Modaressanavi A; Avila E; Foster DB; Zachara NE; O'Rourke B
J Biol Chem; 2023 Mar; 299(3):102907. PubMed ID: 36642184
[TBL] [Abstract][Full Text] [Related]
16. Cardiomyocyte Ogt is essential for postnatal viability.
Watson LJ; Long BW; DeMartino AM; Brittian KR; Readnower RD; Brainard RE; Cummins TD; Annamalai L; Hill BG; Jones SP
Am J Physiol Heart Circ Physiol; 2014 Jan; 306(1):H142-53. PubMed ID: 24186210
[TBL] [Abstract][Full Text] [Related]
17. Cardiomyocyte Ogt limits ventricular dysfunction in mice following pressure overload without affecting hypertrophy.
Dassanayaka S; Brainard RE; Watson LJ; Long BW; Brittian KR; DeMartino AM; Aird AL; Gumpert AM; Audam TN; Kilfoil PJ; Muthusamy S; Hamid T; Prabhu SD; Jones SP
Basic Res Cardiol; 2017 May; 112(3):23. PubMed ID: 28299467
[TBL] [Abstract][Full Text] [Related]
18. E2f1 deletion attenuates infarct-induced ventricular remodeling without affecting O-GlcNAcylation.
Dassanayaka S; Brittian KR; Jurkovic A; Higgins LA; Audam TN; Long BW; Harrison LT; Militello G; Riggs DW; Chitre MG; Uchida S; Muthusamy S; Gumpert AM; Jones SP
Basic Res Cardiol; 2019 May; 114(4):28. PubMed ID: 31152247
[TBL] [Abstract][Full Text] [Related]
19. Cardiac O-GlcNAc signaling is increased in hypertrophy and heart failure.
Lunde IG; Aronsen JM; Kvaløy H; Qvigstad E; Sjaastad I; Tønnessen T; Christensen G; Grønning-Wang LM; Carlson CR
Physiol Genomics; 2012 Feb; 44(2):162-72. PubMed ID: 22128088
[TBL] [Abstract][Full Text] [Related]
20. Role of
Chatham JC; Zhang J; Wende AR
Physiol Rev; 2021 Apr; 101(2):427-493. PubMed ID: 32730113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
